Despite the diverse transcriptional resistance programs observed across tissue types, CDK8/19 inhibition completely prevented lung and colon cancer cells from developing resistance to ERK inhibition (Fig. 2g, bottom), and markedly delayed the emergence of resistance in pancreatic cancer cells. This evidence concerns the gene CDK8 and malignant colon neoplasm.